Login to Your Account



With Immunotherapies, Patients May Live Though Tumors Grow

By Anette Breindl
Science Editor

Monday, June 10, 2013

CHICAGO – At the American Society of Clinical Oncology (ASCO) annual meeting last week, there were plenty of individual trial results vying for attention. But there were also presentations that focused on the science of the trials: how one might make those trials better at observing the true effects of drugs on tumors and, ultimately, on patients.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription